![George Rehm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George Rehm
Director/Board Member at
Barnev, Inc.
Profile
George Rehm is a Director at Barnev, Inc., Jiff, Inc., emPower Health Equity, Inc., OrphAI Therapeutics, Inc., Inkspace Imaging, Inc., and a Venture Partner at EMBL Ventures GmbH.
He previously served as a Director at Crescendo Bioscience LLC, Tethys Bioscience, Inc., Adamas Pharmaceuticals LLC, Solstice Biologics LLC, ViaLogy LLC, and Decipher Biosciences, Inc. He was also a Non-Executive Director at ViaLogy Plc and Sensovation AG, and a Managing Director & Partner at firstVentury Equity GmbH and Calibrium Private Investments GmbH.
Additionally, he served as a Director-Supervisory Board at Sensovation AG and a Member-Supervisory Board at Affimed NV Niederlassung Deutschland.
He received his undergraduate degree from Georgetown University and his graduate degree from the University of California, Hastings.
George Rehm active positions
| Companies | Position | Start |
|---|---|---|
Barnev, Inc.
 Barnev, Inc. Information Technology ServicesTechnology Services Develops, manufactures and distributes labor monitoring systems | Director/Board Member | - |
Jiff, Inc.
 Jiff, Inc. Packaged SoftwareTechnology Services Provides mobile based consumer-centric software platform for the healthcare industry | Director/Board Member | 12/03/2012 |
EMBL Ventures GmbH
 EMBL Ventures GmbH Investment ManagersFinance EMBL Ventures is a hands-on, long-term manager which invests in disruptive biology and life-science related products and technologies with global potential, including therapeutics, target validation and drug design, technology platforms, medical devices and diagnostics developed at the EMBL, from EMBL alumni and from non-EMBL third parties. The firm seeks to invest in entrepreneurial management teams with: a combination of relevant technical expertise, drive, business sense and a down-to-earth attitude; ownership of a proprietary core or platform technology generating a proprietary position or clear competitive advantage in a defined market sector and a solution for a problem with a significant advantage in a market of substantial size and the chance to achieve a leading, sustainable market position. EMBL Ventures typically acts as the lead or co-lead investor for initial financing and also participates in follow-up financing. They partner with their investee companies, taking a seat on the board of directors. To maximize the intrinsic value of a technology or product, the firm's investment strategy targets one of the main value inflection points, typically the transition from early development or conceptual stage up to proof of concept. | Private Equity Investor | - |
AI Therapeutics, Inc.
 AI Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Director/Board Member | 01/06/2015 |
emPower Health Equity, Inc.
 emPower Health Equity, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Director/Board Member | - |
Inkspace Imaging, Inc.
 Inkspace Imaging, Inc. Medical SpecialtiesHealth Technology Develops magnetic resonance imaging surface receive coils | Director/Board Member | 14/04/2023 |
Former positions of George Rehm
| Companies | Position | End |
|---|---|---|
| ADAMAS PHARMACEUTICALS, INC. | Director/Board Member | 15/04/2014 |
Calibrium Private Investments GmbH
 Calibrium Private Investments GmbH Investment ManagersFinance Calibrium Private Invt invests in small and middle market companies located in the United States, Austria, Germany and Switzerland. The firm targets companies operating in the fields of healthcare, consumer products, information technology, energy and business services. It provides financing for early and buyout transactions. | Chief Executive Officer | 02/01/2011 |
Tethys Bioscience, Inc.
 Tethys Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biological markers for the clinical diagnostics marketplace | Director/Board Member | - |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of George Rehm
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
48
1st degree connections
21
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 21 |
|---|---|
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases | Commercial Services |
Tethys Bioscience, Inc.
Tethys Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biological markers for the clinical diagnostics marketplace | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Solstice Biologics LLC
 Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Develops cell-permeable RNAi pro-drugs | Health Technology |
ViaLogy LLC
 ViaLogy LLC Miscellaneous Commercial ServicesCommercial Services Develops technology to improve signal detection against electronic background noise | Commercial Services |
EMBL Ventures GmbH
EMBL Ventures GmbH Investment ManagersFinance EMBL Ventures is a hands-on, long-term manager which invests in disruptive biology and life-science related products and technologies with global potential, including therapeutics, target validation and drug design, technology platforms, medical devices and diagnostics developed at the EMBL, from EMBL alumni and from non-EMBL third parties. The firm seeks to invest in entrepreneurial management teams with: a combination of relevant technical expertise, drive, business sense and a down-to-earth attitude; ownership of a proprietary core or platform technology generating a proprietary position or clear competitive advantage in a defined market sector and a solution for a problem with a significant advantage in a market of substantial size and the chance to achieve a leading, sustainable market position. EMBL Ventures typically acts as the lead or co-lead investor for initial financing and also participates in follow-up financing. They partner with their investee companies, taking a seat on the board of directors. To maximize the intrinsic value of a technology or product, the firm's investment strategy targets one of the main value inflection points, typically the transition from early development or conceptual stage up to proof of concept. | Finance |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Barnev, Inc.
Barnev, Inc. Information Technology ServicesTechnology Services Develops, manufactures and distributes labor monitoring systems | Technology Services |
Sensovation AG
 Sensovation AG Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets scientific imaging instrumentation technologies | Electronic Technology |
firstVentury Equity GmbH
 firstVentury Equity GmbH Investment ManagersFinance Acts as an alternative investment manager | Finance |
ViaLogy Plc
 ViaLogy Plc Electronic Equipment/InstrumentsElectronic Technology Engages in network centric signal processing for sensor applications | Electronic Technology |
TTTech Computertechnik AG
 TTTech Computertechnik AG Packaged SoftwareTechnology Services Develops automated driving systems | Technology Services |
University of California, Hastings
 University of California, Hastings Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calibrium Private Investments GmbH
Calibrium Private Investments GmbH Investment ManagersFinance Calibrium Private Invt invests in small and middle market companies located in the United States, Austria, Germany and Switzerland. The firm targets companies operating in the fields of healthcare, consumer products, information technology, energy and business services. It provides financing for early and buyout transactions. | Finance |
Veracyte SD, Inc.
 Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care | Commercial Services |
Jiff, Inc.
Jiff, Inc. Packaged SoftwareTechnology Services Provides mobile based consumer-centric software platform for the healthcare industry | Technology Services |
PatientWisdom, Inc.
 PatientWisdom, Inc. Packaged SoftwareTechnology Services Develops and operates platform that collects, curates, segments and shares patient stories | Technology Services |
emPower Health Equity, Inc.
emPower Health Equity, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
AI Therapeutics, Inc.
AI Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Inkspace Imaging, Inc.
Inkspace Imaging, Inc. Medical SpecialtiesHealth Technology Develops magnetic resonance imaging surface receive coils | Health Technology |
- Stock Market
- Insiders
- George Rehm
